EDoN Board

The EDoN Board oversees the project, approves the project strategy and plans, and ensures that the provided funding is spent wisely. It offers expert guidance that will help drive forward the initiative. The EDoN Board members, as part of the EDoN initiative, are formal representatives acting in the best interest of EDoN. If you would like to get in touch with the EDoN Board please contact Pippa Palmer.

Chair

DavidCameron

Rt Hon David Cameron

President of Alzheimer's Research UK
Chair of the EDoN Board

Members

Nick Antill

Nick Antill

Alzheimer's Research UK Trustee and Treasurer

Niranjan Bose

Dr Niranjan Bose

Managing Director (Health and Life Sciences Strategy)
Gates Ventures LLC

John Deanfield

John Deanfield

Professor of Cardiology
University College London

Giles Dennison

Giles Dennison

Alzheimer's Research UK Trustee
Partner at Eversheds Sutherland

Phyllis Barkman Ferrell

Phyllis Barkman Ferrell

Global Head of External Engagement for Alzheimer’s Disease and Neurodegeneration
Eli Lilly & Company

Michael Geoghegan

Michael Geoghegan, CBE


Matthew Gould

Matthew Gould CMG MBE

Chief Executive Officer
NHSX

Clive Gringras

Clive Gringras

Head of Technology, Media and Telecommunications
CMS

Fiona Reddington

Dr Fiona Reddington

Executive Director of Strategic Partnerships
Our Future Health